HashiCorp founder Mitchell Hashimoto claims some companies are suffering from "AI psychosis." He argues that leadership is overestimating current capabilities and ignoring fundamental technical limitations. This blind optimism leads to flawed product roadmaps. Practitioners must distinguish between genuine utility and the hype-driven delusions currently infecting corporate decision-making processes at enterprise scale.